Finance

Beta
Lists
300239:SHE
Baotou Dongbao Bio-Tech Co Ltd
CNÂ¥4.83
+2.11%
(+0.100) 1D
Jun 12, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300239...
Open
CNÂ¥4.75
High
CNÂ¥4.84
Low
CNÂ¥4.66
Mkt. cap
2.87B
Avg. vol.
10.16M
Volume
7.49M
Dividend
0.25%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
May 27, 2026
P/E ratio
54.06
52-wk high
CNÂ¥6.82
52-wk low
CNÂ¥4.59
EPS
CNÂ¥0.09
Shares outstanding
593.62M
No. of employees
1K
Open
CNÂ¥4.75
High
CNÂ¥4.84
Low
CNÂ¥4.66
Mkt. cap
2.87B
Avg. vol.
10.16M
Volume
7.49M
Dividend
0.25%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
May 27, 2026
P/E ratio
54.06
52-wk high
CNÂ¥6.82
52-wk low
CNÂ¥4.59
EPS
CNÂ¥0.09
Shares outstanding
593.62M
No. of employees
1K
News stories
From sources across the web
About Baotou Dongbao Bio-Tech Co Ltd
CEO-
Employees1.42K
Founded1960
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
181.02M
163.74M
212.51M
190.53M
Cost of goods sold
137.74M
123.47M
185.23M
144.26M
Cost of revenue
137.74M
123.47M
185.23M
144.26M
Research and development expenses
6.75M
6.43M
6.57M
5.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.53M
16.14M
19.58M
15.85M
Operating expense
26.83M
17.37M
36.98M
20.30M
Total operating expenses
164.57M
140.84M
222.21M
164.56M
Operating income
16.45M
22.90M
-9.70M
25.97M
Other non operating income
-252.30K
166.38K
-319.33K
-166.39K
EBT including unusual items
19.97M
13.49M
6.02M
23.11M
EBT excluding unusual items
15.34M
22.65M
-9.96M
25.59M
Income tax expense
2.05M
2.01M
136.93K
3.41M
Effective tax rate
10.25%
14.92%
2.27%
14.77%
Other operating expenses
3.70M
-5.11M
9.60M
-235.71K
Net income
17.92M
11.48M
5.89M
19.69M
Net profit margin
9.90%
7.01%
2.77%
10.34%
Earnings per share
-
-
-
-
Interest and investment income
511.89K
637.08K
795.73K
644.07K
Interest expense
-1.54M
-882.20K
-860.70K
-855.96K
Net interest expenses
-1.03M
-245.12K
-64.97K
-211.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
40.05M
44.48M
14.59M
50.26M
Gain or loss from assets sale
310.27K
-310.27K
93.37K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more